• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

转化生长因子-β1 在隐性营养不良型大疱性表皮松解症鳞癌中的作用。

Role of transforming growth factor-β1 in recessive dystrophic epidermolysis bullosa squamous cell carcinoma.

机构信息

Stem Cell Institute, University of Minnesota, Minneapolis, MN, USA.

Department of Pediatrics, Blood and Marrow Transplantation, University of Minnesota, Minneapolis, MN, USA.

出版信息

Exp Dermatol. 2021 May;30(5):664-675. doi: 10.1111/exd.14304. Epub 2021 Feb 28.

DOI:10.1111/exd.14304
PMID:33595864
Abstract

Squamous cell carcinoma (SCC) develops in more than 80% of individuals with the skin blistering disorder recessive dystrophic epidermolysis bullosa (RDEB). In contrast with UV-induced SCC, RDEB-SCC results from skin damage and has a high proliferative and metastatic rate with 5-year survival near zero. Our objective is to determine the mechanisms underlying the increased metastatic tendencies of RDEB-SCC. RDEB-SCC cultured cell lines were treated with RDEB and non-RDEB fibroblast conditioned media and assayed for migration and invasion with and without small molecule inhibitors for TGFβ and other downstream signal transduction pathways. TGFβ1 secreted by RDEB dermal fibroblasts has been found to induce migration and invasion and to increase expression of epithelial-to-mesenchymal transition markers in an RDEB-SCC line. These effects were reversed upon inhibition of TGFβ signalling and its downstream pathways MEK/ERK, P38 kinase and SMAD3. A number of small molecule inhibitors for these pathways are in different phases of various clinical trials and may be applicable to RDEB-SCC patients. Studying the mechanisms of the extreme form RDEB-SCC may inform studies of other types of SCC, as well as lead to better therapies for RDEB patients.

摘要

鳞状细胞癌(SCC)在超过 80%的隐性营养不良性大疱性表皮松解症(RDEB)皮肤水疱病患者中发展。与 UV 诱导的 SCC 不同,RDEB-SCC 是由皮肤损伤引起的,具有高增殖和转移率,5 年生存率接近零。我们的目标是确定 RDEB-SCC 转移趋势增加的机制。用 RDEB 和非 RDEB 成纤维细胞条件培养基处理 RDEB-SCC 培养细胞系,并在有和没有 TGFβ和其他下游信号转导途径的小分子抑制剂的情况下检测迁移和侵袭。已经发现 RDEB 真皮成纤维细胞分泌的 TGFβ1 诱导 RDEB-SCC 系的迁移和侵袭,并增加上皮-间充质转化标志物的表达。这些效应在 TGFβ信号及其下游途径 MEK/ERK、P38 激酶和 SMAD3 被抑制时被逆转。这些途径的许多小分子抑制剂处于不同的临床试验阶段,可能适用于 RDEB-SCC 患者。研究 RDEB-SCC 的极端形式的机制可能会为其他类型的 SCC 研究提供信息,并为 RDEB 患者提供更好的治疗方法。

相似文献

1
Role of transforming growth factor-β1 in recessive dystrophic epidermolysis bullosa squamous cell carcinoma.转化生长因子-β1 在隐性营养不良型大疱性表皮松解症鳞癌中的作用。
Exp Dermatol. 2021 May;30(5):664-675. doi: 10.1111/exd.14304. Epub 2021 Feb 28.
2
TGFβ-signaling in squamous cell carcinoma occurring in recessive dystrophic epidermolysis bullosa.隐性营养不良型大疱性表皮松解症相关鳞状细胞癌中的 TGFβ 信号通路。
Anal Cell Pathol (Amst). 2011;34(6):339-53. doi: 10.3233/ACP-2011-0039.
3
Impaired Wound Healing, Fibrosis, and Cancer: The Paradigm of Recessive Dystrophic Epidermolysis Bullosa.创伤愈合受损、纤维化和癌症:隐性营养不良性大疱性表皮松解症的范例。
Int J Mol Sci. 2021 May 12;22(10):5104. doi: 10.3390/ijms22105104.
4
Suppression of TGFβ and Angiogenesis by Type VII Collagen in Cutaneous SCC.VII 型胶原对皮肤 SCC 中 TGFβ 和血管生成的抑制作用。
J Natl Cancer Inst. 2015 Oct 16;108(1). doi: 10.1093/jnci/djv293. Print 2016 Jan.
5
MicroRNA-200b-mediated reversion of a spectrum of epithelial-to-mesenchymal transition states in recessive dystrophic epidermolysis bullosa squamous cell carcinomas.微小 RNA-200b 介导的隐性营养不良型大疱性表皮松解症鳞状细胞癌中一系列上皮间质转化状态的逆转。
Br J Dermatol. 2023 Dec 20;190(1):80-93. doi: 10.1093/bjd/ljad335.
6
Update on the pathogenesis of squamous cell carcinoma development in recessive dystrophic epidermolysis bullosa.隐性营养不良型大疱性表皮松解症中鳞状细胞癌发生机制的最新进展
Eur J Dermatol. 2015 Apr;25 Suppl 1:30-2. doi: 10.1684/ejd.2015.2552.
7
Transformation-specific matrix metalloproteinases (MMP)-7 and MMP-13 are expressed by tumour cells in epidermolysis bullosa-associated squamous cell carcinomas.在大疱性表皮松解症相关的鳞状细胞癌中,肿瘤细胞表达转化特异性基质金属蛋白酶(MMP)-7和MMP-13。
Br J Dermatol. 2008 Apr;158(4):778-85. doi: 10.1111/j.1365-2133.2008.08466.x. Epub 2008 Feb 16.
8
Identification of Rigosertib for the Treatment of Recessive Dystrophic Epidermolysis Bullosa-Associated Squamous Cell Carcinoma.鉴定利戈塞替尼治疗隐性营养不良型大疱性表皮松解症相关鳞状细胞癌。
Clin Cancer Res. 2019 Jun 1;25(11):3384-3391. doi: 10.1158/1078-0432.CCR-18-2661. Epub 2019 Mar 7.
9
APOBEC mutation drives early-onset squamous cell carcinomas in recessive dystrophic epidermolysis bullosa.APOBEC 突变驱动隐性营养不良性大疱性表皮松解症的早发性鳞状细胞癌。
Sci Transl Med. 2018 Aug 22;10(455). doi: 10.1126/scitranslmed.aas9668.
10
Reduced expression of insulin-like growth factor-binding protein-3 (IGFBP-3) in Squamous cell carcinoma complicating recessive dystrophic epidermolysis bullosa.胰岛素样生长因子结合蛋白-3(IGFBP-3)在隐性营养不良性大疱性表皮松解症并发鳞状细胞癌中的表达降低。
J Invest Dermatol. 2004 May;122(5):1302-9. doi: 10.1111/j.0022-202X.2004.22525.x.

引用本文的文献

1
Chondroitin sulfate proteoglycan 4 increases invasion of recessive dystrophic epidermolysis bullosa-associated cutaneous squamous cell carcinoma by modifying transforming growth factor-β signalling.硫酸软骨素蛋白聚糖4通过调节转化生长因子-β信号通路增加隐性营养不良型大疱性表皮松解症相关皮肤鳞状细胞癌的侵袭性。
Br J Dermatol. 2024 Dec 23;192(1):104-117. doi: 10.1093/bjd/ljae295.
2
Therapies for cutaneous squamous cell carcinoma in recessive dystrophic epidermolysis bullosa: a systematic review of 157 cases.隐性营养不良型大疱性表皮松解症皮肤鳞状细胞癌的治疗:157 例系统性回顾。
Orphanet J Rare Dis. 2024 May 21;19(1):206. doi: 10.1186/s13023-024-03190-1.
3
A tEMTing target? Clinical and experimental evidence for epithelial-mesenchymal transition in the progression of cutaneous squamous cell carcinoma (a scoping systematic review).
一个诱人的靶点?皮肤鳞状细胞癌进展中上皮-间质转化的临床和实验证据(一项范围界定性系统评价)
Discov Oncol. 2022 Jun 6;13(1):42. doi: 10.1007/s12672-022-00510-4.
4
Interrogation of RDEB Epidermal Allografts after BMT Reveals Coexpression of Collagen VII and Keratin 15 with Proinflammatory Immune Cells and Fibroblasts.BMT 后 RDEB 表皮同种异体移植物的检测显示,胶原 VII 和角蛋白 15 与促炎免疫细胞和成纤维细胞共同表达。
J Invest Dermatol. 2022 Sep;142(9):2424-2434. doi: 10.1016/j.jid.2022.01.034. Epub 2022 Mar 15.
5
Clinical Perspectives of Gene-Targeted Therapies for Epidermolysis Bullosa.大疱性表皮松解症基因靶向治疗的临床前景
Dermatol Ther (Heidelb). 2021 Aug;11(4):1175-1197. doi: 10.1007/s13555-021-00561-5. Epub 2021 Jun 10.
6
Impaired Wound Healing, Fibrosis, and Cancer: The Paradigm of Recessive Dystrophic Epidermolysis Bullosa.创伤愈合受损、纤维化和癌症:隐性营养不良性大疱性表皮松解症的范例。
Int J Mol Sci. 2021 May 12;22(10):5104. doi: 10.3390/ijms22105104.